10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,747 | -166,000 | -148,785 | -106,871 | -42,413 |
| Depreciation Amortization | 8,616 | 33,006 | 24,534 | 16,419 | 8,158 |
| Accounts receivable | 26,279 | -18,948 | 1,673 | 9,025 | 8,728 |
| Accounts payable and accrued liabilities | -781 | 5,858 | 6,082 | 10,262 | 2,875 |
| Other Working Capital | -5,960 | -40,342 | -20,072 | -10,133 | -12,594 |
| Other Operating Activity | 18,468 | 152,820 | 89,239 | 43,533 | 14,444 |
| Operating Cash Flow | $-4,125 | $-33,606 | $-47,329 | $-37,765 | $-20,802 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 125,238 | -215,226 | -224,288 | -229,730 | -229,422 |
| PPE Investments | -4,559 | -131,661 | -91,927 | -55,355 | -28,136 |
| Net Acquisitions | N/A | -4,000 | -1,500 | N/A | N/A |
| Purchase Sale Intangibles | -723 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -723 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $119,956 | $-350,887 | $-317,715 | $-285,085 | $-257,558 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,814 | -5,409 | -5,409 | -5,409 | -5,409 |
| Common Stock Issued | 2,400 | 21,226 | 16,225 | 14,186 | 7,826 |
| Financing Cash Flow | $-3,414 | $15,817 | $10,816 | $8,777 | $2,417 |
| Exchange Rate Effect | 24 | -44 | -295 | -210 | -18 |
| Beginning Cash Position | 227,353 | 596,073 | 596,073 | 596,073 | 596,073 |
| End Cash Position | 339,794 | 227,353 | 241,550 | 281,790 | 320,112 |
| Net Cash Flow | $112,441 | $-368,720 | $-354,523 | $-314,283 | $-275,961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,125 | -33,606 | -47,329 | -37,765 | -20,802 |
| Capital Expenditure | -4,559 | -131,661 | -91,927 | -55,355 | -28,136 |
| Free Cash Flow | -8,684 | -165,267 | -139,256 | -93,120 | -48,938 |